Maximus, Inc. (NYSE:MMS) insider Mark Andrekovich sold 5,000 shares of Maximus stock in a transaction dated Tuesday, December 5th. The stock was sold at an average price of $68.80, for a total value of $344,000.00. Following the transaction, the insider now directly owns 22,996 shares in the company, valued at $1,582,124.80. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website.
Mark Andrekovich also recently made the following trade(s):
- On Wednesday, November 22nd, Mark Andrekovich sold 5,594 shares of Maximus stock. The stock was sold at an average price of $67.23, for a total value of $376,084.62.
Shares of Maximus, Inc. (NYSE MMS) traded up $0.68 during trading hours on Friday, hitting $70.82. The stock had a trading volume of 420,400 shares, compared to its average volume of 359,100. The firm has a market cap of $4,525.69, a P/E ratio of 22.34, a price-to-earnings-growth ratio of 2.61 and a beta of 1.35. Maximus, Inc. has a 12 month low of $51.74 and a 12 month high of $70.83.
The firm also recently disclosed a quarterly dividend, which was paid on Thursday, November 30th. Stockholders of record on Wednesday, November 15th were paid a $0.045 dividend. This represents a $0.18 dividend on an annualized basis and a dividend yield of 0.25%. The ex-dividend date of this dividend was Tuesday, November 14th. Maximus’s dividend payout ratio is 5.66%.
Several large investors have recently made changes to their positions in the company. Vanguard Group Inc. lifted its stake in shares of Maximus by 2.4% in the 2nd quarter. Vanguard Group Inc. now owns 5,669,026 shares of the health services provider’s stock valued at $355,052,000 after purchasing an additional 130,839 shares during the period. FMR LLC increased its position in Maximus by 10.4% in the 2nd quarter. FMR LLC now owns 4,658,584 shares of the health services provider’s stock valued at $291,767,000 after buying an additional 438,025 shares in the last quarter. Victory Capital Management Inc. increased its position in Maximus by 13.3% in the 3rd quarter. Victory Capital Management Inc. now owns 3,514,228 shares of the health services provider’s stock valued at $226,667,000 after buying an additional 413,325 shares in the last quarter. Janus Henderson Group PLC increased its position in Maximus by 718.8% in the 2nd quarter. Janus Henderson Group PLC now owns 2,211,638 shares of the health services provider’s stock valued at $138,515,000 after buying an additional 1,941,521 shares in the last quarter. Finally, State Street Corp increased its position in Maximus by 3.5% in the 2nd quarter. State Street Corp now owns 2,138,049 shares of the health services provider’s stock valued at $133,906,000 after buying an additional 71,823 shares in the last quarter. 94.82% of the stock is currently owned by institutional investors.
A number of brokerages have recently issued reports on MMS. Zacks Investment Research raised Maximus from a “hold” rating to a “buy” rating and set a $73.00 price objective on the stock in a research note on Wednesday, October 4th. Canaccord Genuity dropped their price objective on Maximus from $62.00 to $61.00 and set a “hold” rating on the stock in a research note on Friday, November 10th. Finally, Robert W. Baird reissued a “hold” rating and issued a $64.00 price objective on shares of Maximus in a research note on Friday, September 1st. Two equities research analysts have rated the stock with a sell rating and six have assigned a hold rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus target price of $64.33.
Maximus Company Profile
MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.
Receive News & Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related companies with MarketBeat.com's FREE daily email newsletter.